ARTMS’ system may ease cost, shortage of valuable radioisotopes

ARTMS Products (Vancouver, B.C) has won the CE mark for its first-in-class, advanced technology Quantm irradiation system, designed to produce high-value medical imaging isotopes such as technetium-99m (Tc-99m) on medical cyclotrons. Tc-99m is given to nearly 50,000 Americans every day to diagnose cancer and heart disease. It is used in more than 80% of all nuclear

Medtech stories we missed this week: August 3, 2018

From Esaote launching its new ultrasound device to Nipro’s Infraredx launching in Japan, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Esaote launches new ultrasound devices Esaote announced in an Aug. 2 press release that it has launched its new MyLab X7, MyLab X6 and MyLab X5 ultrasound systems.

Sensus squeaks past Wall Street Q2 expectations

Sensus Healthcare (NSDQ:SRTS), narrowly beat analysts’ earnings expectations for the second quarter but missed the consensus sales forecast, sending share prices down today. Boca Raton, Fla.-based Sensus posted net losses of -$540,651, or -4¢ per share, on sales of $6.1 million for the three months ended June 30, cutting its losses by -29.2% on sales growth

Medtech stories we missed this week: July 27, 2018

From the FDA clearing LifeSignal’s wireless ECG to Zavation receiving FDA clearance for its expandable corpectomy cage, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. FDA clears LifeSignal’s wireless ECG LifeSignals announced in a July 26 press releasethat it has received FDA clearance for its wireless LP1100 Life Signal

Netflix’s ‘The Bleeding Edge’ blasts medtech & FDA

Netflix has unleashed a blistering indictment of the medical device industry, the FDA and doctors who accept money from medtech in its new documentary, ‘The Bleeding Edge,’ released today. The film depicts people who have suffered injuries and/or illnesses following placement of Bayer’s Essure sterilization device, Johnson & Johnson’s vaginal mesh, various manufacturers’ metal artificial

Endomagnetics’ device could help ID cancerous lymph nodes

The FDA has approved Endomagnetics Inc.’s magnetic device system for guiding lymph node biopsies in breast cancer patients undergoing a mastectomy. The  Sentimag Magnetic Localization System detects magnetic seeds or a magnetic drug to identify the specific lymph nodes to which cancer cells are most likely to spread from the original tumor. A biopsy of

Medtech companies raised more than $738 million in Q2

Venture capital firms invested more than $738 million during the second quarter of 2018, $1 million less than the first quarter of this year, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There was a total of 61 deals during Q2, an increase from the 48 that the industry saw during Q1.

Key Surgical acquires Encompas Unlimited

Key Surgical recently announced that it has acquired Encompas Unlimited to expand its endoscopy product offerings. The financial details of the deal were not disclosed. This is the second acquisition that Key Surgical has completed after merging with Interlock Medizintechnik last year. Emcompas specializes in manufacturing, assembling and distribution a variety of endoscopy accessories and

Trump tariffs place nearly $1 billion in duties on the medtech industry

The U.S. medical device industry is facing nearly $1 billion in tariffs from the Trump administration, about $4 billion less than what was originally expected, according to AdvaMed. Customs and Border Protection began collecting the additional duties on July 6. The Trump administration announced in April that it intended to impose tariffs on $50 billion

Could this system make more kidneys, livers usable for transplant?

An Italian startup has teamed with critical-care immunotherapy company CytoSorbents Corporation (NASDAQ: CTSO) on an integrated ex-vivo system to perfuse, cleanse, recondition and preserve harvested kidneys and livers — including those that are usually discarded. Aferetica srl (Mirandola, Italy) designed its PerLife system is to improve organ function and viability while reducing the risk of primary graft failure

Medtech stories we missed this week: July 6, 2018

From Zetta getting FDA clearance to Prescient Medical receiving CE Mark approval, here are five medtech stories we missed this week but thought were still worth mentioning. 1. Zetta wins FDA clearance for Zoom MRI software Zetta announced in a June 25 press release that its MRI software has received FDA 510(k) clearance. The software, known as

This algorithm analyzes medical images 1,000 times faster than usual

Massachusetts Institute of Technology researchers have developed an algorithm that makes it easier and 1,000 times quicker to analyze medical images and 3D scans. Medical image registration is a technique that uses two medical images, such as MRI images, to compare and analyze the anatomical differences in detail. In this technique, doctors overlay images from

Resonetics acquires Swiss manufacturer Medelec

Resonetics (Nashua, N.H.) announced today that it has acquired Medelec (Puidoux, Switzerland). The financial details of the deal were not disclosed. “We are excited about the Medelec team joining Resonetics. Marc and Sandra But have established a very strong reputation in the medtech industry for precision and quality and have made significant investments in technology

Bluebee receives ISO 13485 certification

Bluebee recently announced that it has received ISO 13485 medical device quality standard certification for its design and development of software solutions and data processing algorithms intended for use in diagnostics and clinical reporting. The certification body BSI certified that Bluebee’s design, development, installation, testing and servicing of custom-made software solutions and data processing algorithms

No-shows at radiology can cost a hospital $1 million a year, study says

People who fail to show up for radiology appointments cost hospitals about $1 million per year on average, according to a new study. That’s as much as the cost of a new 3T MR scanner. Most of the no-shows at academic medical centers were for mammography appointments, according to the study, published in Current Problems